RGPX · As filed with the SEC
Regenerex Pharma balance sheet, by fiscal year
The statement as Regenerex Pharma presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.
BALANCE SHEETS · USD
| USD | FY2024 Mar 31, 2025 | FY2023 Mar 31, 2024 | FY2023 Mar 31, 2023 | FY2022 Mar 31, 2022 | FY2020 Mar 31, 2021 | FY2019 Mar 31, 2020 | FY2018 Mar 31, 2019 | FY2017 Mar 31, 2018 |
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Cash and Cash Equivalents | 653,025 | 372 | 1,135 | 2,640 | 6,902 | 5,460 | 88,546 | 1,728 |
| Prepaid Expenses | 350 | 2,540 | — | 5,256 | 1,213 | — | 9,070 | — |
| Inventory | — | — | — | — | — | 246,691 | — | — |
| Total Current Assets | 653,375 | 2,912 | 1,135 | 7,896 | 8,115 | 252,151 | 97,616 | 1,728 |
| Intangible Assets | — | 1,328 | 4,203 | 7,426 | 2,355 | 7,016 | 8,007 | 13,341 |
| Property, Plant and Equipment | 5,599 | 6,097 | 1,201 | — | — | — | — | — |
| Operating Lease Right-of-Use Asset | 604,262 | 756,343 | — | — | — | — | — | — |
| Total Assets | 1,263,236 | 766,680 | 6,539 | 15,322 | 10,470 | 259,167 | 105,623 | 15,069 |
| LIABILITIES AND STOCKHOLDERS’ DEFICIT | ||||||||
| Accounts Payable | 197,673 | 116,760 | 75,145 | 63,027 | 48,038 | 51,098 | 38,348 | 37,870 |
| Other Non-Operating Current Liabilities | — | — | 131,887 | 131,687 | 130,992 | 130,992 | 130,990 | 67,113 |
| Related party advances | 13,652 | 3,690 | — | — | — | — | — | — |
| Accrued Compensation and Benefits | 842,620 | 511,847 | 221,192 | 221,192 | 221,192 | 221,192 | 221,192 | 221,192 |
| Other Current Liabilities | 88,268 | 97,251 | 125,787 | 91,667 | 71,003 | 45,436 | 14,778 | 10,000 |
| Short-Term Debt | 2,824,232 | 2,400,000 | 222,771 | 152,880 | 150,094 | 70,000 | — | — |
| Shareholder | 469,105 | 475,050 | — | — | — | — | — | — |
| Other Affiliates | 306,103 | 110,500 | — | — | — | — | — | — |
| Operating Lease Liability, Current | 181,894 | 128,264 | — | — | — | — | — | — |
| Total Current Liabilities | 4,923,547 | 3,843,362 | 776,782 | 660,453 | 621,319 | 518,718 | 405,308 | 336,175 |
| Long-Term Debt | — | 119,114 | 314,704 | 340,486 | 224,177 | 221,723 | 70,000 | — |
| Notes payable to related parties, net of current portion | — | — | 38,000 | — | — | — | — | — |
| Long-Term Debt | — | 184,232 | — | — | — | — | — | — |
| Operating Lease Liability, Non-Current | 495,894 | 681,798 | — | — | — | — | — | — |
| Total Liabilities | 5,419,441 | 4,828,506 | 1,129,486 | 1,000,939 | 845,496 | 740,441 | 475,308 | — |
| Stockholders’ Deficit | ||||||||
| Total Stockholders' Equity | 281,071 | 278,226 | 277,113 | 277,113 | 127,113 | 127,113 | 127,113 | 127,113 |
| Additional Paid-In Capital | 3,705,615 | 1,275,798 | 671,963 | 671,963 | 776,963 | 776,963 | 776,963 | 731,963 |
| Retained Earnings | (8,142,891) | (5,615,850) | (2,072,023) | (1,934,693) | (1,739,102) | (1,385,350) | (1,273,761) | (1,180,182) |
| Total Equity | (4,156,205) | (4,061,826) | (1,122,947) | (985,617) | (835,026) | (481,274) | (369,685) | (321,106) |
| Total Liabilities and Equity | 1,263,236 | 766,680 | 6,539 | 15,322 | 10,470 | 259,167 | 105,623 | 15,069 |
As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.